Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor

Thrombosis Research

Volumn 111, Issue 4-5, 2003, Pages 235-238

  Liebman, Howard A ^a   Feinstein, Donald I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Paroxysmal nocturnal hemoglobinuria; Thrombosis; Tissue factor

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; D DIMER; ENOXAPARIN; ERYTHROPOIETIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BRAIN INFARCTION; CASE REPORT; CIRCULATION; CLINICAL FEATURE; DERIVATIZATION; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HEMOLYSIS; HEMOSTASIS; HUMAN; LABORATORY TEST; LEUKOCYTE; LOW DRUG DOSE; MACROPHAGE; MALE; MESENTERIC ARTERY; MONOCYTE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECURRENT DISEASE; SAGITTAL SINUS THROMBOSIS; THROMBOSIS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 0346433810     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.09.018     Document Type: Article

References (25)

1. Rosse W.F. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood. 75:1990;1595-1601.
2. Hillmen R., Lewis S.M., Bessler M., Luzzatto L., Dacie J.V. Natural history of paroxysmal nocturnal hemoglobinuria. N.E.J.M. 333:1995;1253-1258.
3. Socie G., Mary J.-Y., deGramont A., Rio B., Leporrier M., Rose C.et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Br. J. Haematol. 348:1996;573-577.
4. Ray J.G., Burows R.F., Ginsberg J.S., Burrows E.A. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for the management of the pregnant and nonpregnant patient. Haemostasis. 30:1999;103-117.
5. Hugel B., Socie G., Vu T., Tou F., Gluckman E., Freyssinet J.-M.et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood. 93:1999;3451-3456.
6. Wiedmer T., Hall S.E., Ortel T.L., Kane W.H., Rosse W.F., Simms P.J. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood. 82:1993;1192-1196.
7. Gralnick H.R., Vail M., McKeown L.P., Merryman P., Wilson O., Chu I.et al. Activated platelets in paroxysmal nocturnal haemoglobinuria. Br. J. Haematol. 91:1995;697-702.
8. Ronne E., Pappot H., Grondahl-Hansen J., Hoyer-Hansen G., Plesner T., Hansen N.E.et al. The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br. J. Haematol. 89:1995;576-581.
9. Plesner T., Behrendt N., Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells. 15:1997;398-408.
10. Ninomiya H., Hasegawa Y., Nagasawa T., Abe T. Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity. Int. J. Hematol. 65:1997;285-291.
11. Weitz I.C., Israel V.K., Waisman J.R., Presant C., Rochanda L., Liebman H.A. Chemotherapy-induced hemostatic activation: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of activation. Thromb. Haemost. 88:2002;213-220.
12. Osterud B., Bjorklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand. J. Haematol. 29:1982;175-184.
13. Shands J.W. The endotoxin induced procoagulant of mouse exudates macrophages: a factor X activator. Blood. 62:1983;333-339.
14. Balasubramanian V., Grabowski E., Bini A., Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood. 100:2002;2787-2792.
15. Falati S., Gross P., Merrill-Skoloff G., Furie B.C., Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat. Med. 8:2002;1175-1181.
16. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood. 88:1996;3259-3287.
17. Norman K.E., Katopodis A.G., Thoma G., Kolbinger F., Hicks A.E., Cotter M.J.et al. P-selectin glycoprotein ligand-1 support rolling on E- and P-selectin in vivo. Blood. 96:2000;3585-3591.
18. Amiral J., Bridey F., Wolf M., Boyer-Neumann C., Fressinaud E., Vissac A.M.et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb. Haemos. 73:1995;21-28.
19. Warkentin T.E., Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia. N. Engl. J. Med. 344:2001;1286-1292.
20. Pouplard C., Iochmann S., Renard B., Herault O., Colombat P., Amiral J. et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood. 2001;3300-3302.
21. Herbert J.M., Savi P., Jeske W.P., Walenga J.M. Effect of SR121566A, a potent GPIIb-IIIa antagonist on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells. Thromb. Haemos. 80:1998;326-331.
22. Warkentin T.E., Kelton J.G. A 14 year study of heparin-induced thrombocytopenia. Am. J. Med. 101:1996;502-507.
23. Gayer G., Zandman-Goddard G., Raanani P., Hertz M., Apter S. Widespread abdominal venous thrombosis in paroxysmal nocturnal hemoglobinuria diagnosed on CT. Abdom. Imaging. 26:2001;414-419.
24. Graham M., Rosse W., Halprein E., Miller C.R., Ware R.E. Resolution of syndrome Budd-Chiari bone following transplantion marrow for paroxysmal nocturnal hemoglobinuria. Br. J. Haematol. 92:1995;707-710.
25. Doukas M.A., Fleming D., Jennings D. Identical twin marrow transplantation for venous thrombosis in paroxysmal nocturnal hemoglobinuria; long-term complete remission as assessed by flow cytometry. Bone Marrow Transplant. 22:1998;717-721.